Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0007134|renal cell carcinoma |
Sentences | 2 |
PubMedID- 23924450 | Evaluation of efficacy and safety of sunitinib regimen in 22 patients with metastatic renal cell carcinoma: at least 12-month follow-up. |
PubMedID- 22013228 | This study assessed the response rates and toxicity profiles of sunitinib on a continuous once-daily dosing regimen in turkish patients with metastatic renal cell carcinoma. |
Page: 1